Outset Medical, Inc. Q2 2026 Earnings Recap

Shares declined 4.3% as investors reacted negatively to deceleration in product and consumable revenue growth and a cautious outlook implied by muted full-year guidance reaffirmation amidst challenging comps.

Key Takeaways

• Revenue rose 1% year-over-year to $31.6 million, reflecting minimal top-line growth.
• Product revenue declined 5% year-over-year, pressured by a 12% drop in consumables despite a 6% increase in console sales.
• Service and other revenue grew 17%, driven by volume and price increases, partially offsetting weakness in product segments.
• Gross margin improved to 42% on a non-GAAP basis, reflecting ongoing margin expansion efforts.
• Full-year 2026 revenue guidance was reiterated at $125 million to $130 million, signaling cautious expectations without upward revision.